Form 4 for ALDX Aldeyra Therapeutics, Inc.
Accepted 2022-04-01 00:00:00 ET · period of report 2022-03-30 · accession 0000899243-22-013174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-01 | 2022-03-30 | ALDX | Reed Joshua | CFO | A - Grant | $0.00 | +93.3K | 274.8K | +51% | $0 |
| D | 2022-04-01 | 2022-03-30 | ALDX | Reed Joshua | CFO | A - Grant | $0.00 | +250.0K | 250.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-30 | A | A | 93,322 | $0.00 | 274,825 | D | — | — | (F1) Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. (F2) Includes 8,022 shares previously purchased under the Issuer's Employee Stock Purchase Plan. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2022-03-30 | A | A | 250,000 | $0.00 | 250,000 | D | $4.52 · — to 2032-03-29 | 250,000 Common Stock | (F3) The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2022. |